Hong Kong Investment Corporation announced a partnership with BlueRun Ventures to launch the "Co-Investment Partnership Program," aimed at advancing Chinese technology companies' global expansion.

On May 22, the inaugural International Patient Capital Forum, hosted by Hong Kong Investment Corporation Limited (HKIC), officially opened. At the event, HKIC announced a "Co-Investment Partnership Program" with BlueRun Ventures to advance a portfolio of co-investment projects, with a focus on supporting globally-minded Chinese tech entrepreneurs and world-leading technological innovation, and driving China's technological capabilities onto the global stage.

Amid geopolitical uncertainty and market volatility, the forum provided a platform for international patient capital investors to focus on capturing future trends in market growth and investment opportunities arising from technological innovation and commercialization. The forum brought together 80 patient capital institutions from around the world, totaling approximately 400 guests from 15 countries, with combined assets under management of $20 trillion. These patient capital institutions — from Europe, the United States, Australia, Japan, and Global South markets including the Middle East and Southeast Asia — encompass sovereign wealth funds, pension funds, university endowments, family offices, and corporate venture arms. Representatives from startups and investment institutions across various sectors also participated.

Mr. Paul Chan Mo-po, Financial Secretary of the Hong Kong Special Administrative Region Government, stated at the forum: "Technological transformation is accelerating the reshaping of the global economy, with new technologies and new pathways constantly emerging. This brings both opportunities and the challenge of exploring the unknown. In this process, we need patient capital with a long-term vision to support technological innovation and accelerate commercialization. We also need the combined force of international capital to translate these innovations and breakthroughs into benefits for people around the world. This forum serves as an international platform that brings together patient capital from across the globe and connects it with cutting-edge technology projects. As an international financial and innovation hub, Hong Kong is committed to efficiently connecting capital, technology, and talent, and to working with international partners to open new pathways for innovation and achieve mutual success."

Image caption: Mr. Paul Chan Mo-po, Financial Secretary of the Hong Kong Special Administrative Region Government, delivers his address.

Ms. Clara Chan Ka-kei, CEO of HKIC, noted: "The gathering of numerous top-tier international patient capital institutions at this forum reflects the strong demand from global long-term capital for strategic positioning amid technological transformation, particularly during this explosive phase of artificial intelligence. As an international hub, Hong Kong provides an efficient platform for investors to deeply engage with frontier technology companies and grasp trends in technology commercialization and capital dynamics. HKIC adheres to a long-term philosophy and is committed to building a cross-regional 'circle of friends' to facilitate precise matching between patient capital and innovative enterprises. Through this platform, we look forward to establishing regular exchange arrangements with more international capital, attracting more international long-term capital to invest together, accelerating the growth of technology companies, and enabling frontier technologies to truly become drivers of global progress, achieving win-win development."

Image caption: Ms. Clara Chan Ka-kei, CEO of Hong Kong Investment Corporation Limited, delivers her address.

During the forum, BlueRun Ventures hosted a discussion session titled "Connecting the World — Uncovering Innovation Opportunities," which delved into China's pivotal role in the global technological innovation landscape and how patient capital can propel Chinese tech enterprises onto the world stage.

Terry Zhu, Managing Partner of BlueRun Ventures, proposed that global technological innovation is entering a new era, with China gradually becoming a powerhouse of global technological innovation — not merely a manufacturing hub, but an innovation hub. China's top talent and enterprises are exerting transformative influence in key domains and reshaping global standards. In the new AI cycle, BlueRun Ventures has developed a forward-looking AI investment thesis: the "triple wave convergence" of AI + 3D interaction + robotics will be the defining theme of technological transformation over the next 30 years. At the same time, BlueRun Ventures is closely tracking the globalization of Chinese technology and talent mobility trends, investing in and deploying capital toward Chinese innovative enterprises with a global vision.

Terry Zhu stated that patient capital plays a critical role in driving technological development by providing long-term financial support, accelerating the integration of technology with industry, and building ecosystems. As one of China's largest early-stage technology funds, BlueRun Ventures has supported numerous outstanding entrepreneurs in making the leap from zero to one; the subsequent success of technological progress and industrial transformation then requires the participation of more international patient capital. As a representative of patient capital, HKIC not only provides long-term funding for companies in their expansion phase, but also collaborates with early-stage technology fund managers to invest early and small, thereby building a more complete innovation ecosystem.

"We are honored to have a strategic partner and investor like HKIC working alongside us to co-invest in globally-minded Chinese tech entrepreneurs and world-leading technological innovation. This fund has already been launched, and more investment projects will be seen within the year," said Terry Zhu.

Image caption: Terry Zhu, Managing Partner of BlueRun Ventures, delivers his address.

Yao Xin, Co-founder and CEO of PPIO, shared from the perspective of a serial entrepreneur the changes he sees in the current technological transformation, as well as China's advantages and leading position in technology globally. As a technology company focused on global computing resource scheduling, PPIO is dedicated to solving the mismatch between computing supply and demand. Based on its technological strengths, PPIO is able to offer competitive pricing on a global scale. Over the past six months, the platform's daily token consumption has grown from 800 million to 150 billion, demonstrating strong business momentum. PPIO's products serve not only Chinese companies but are also well-received by globally renowned clients.

Image caption: Yao Xin, Co-founder and CEO of PPIO

Cheng Haotian, Founder and CEO of Gaussian Robotics, stated that as a global leader in AI-driven autonomous cleaning solutions, Gaussian Robotics serves more than 4,000 clients across over 70 countries and regions, with overseas revenue accounting for more than 80% of total revenue. The company holds approximately 50% market share overseas and about 90% in China. Drawing lessons from the development path of China's new energy vehicle industry, Gaussian Robotics emphasizes integrating its business with China's dual advantages as both a manufacturing center and innovation center, fully absorbing the benefits of talent, supply chains, policy support, and vast markets to achieve rapid company growth. Cheng Haotian proposed that if Chinese enterprises can fully leverage their comparative advantages and integrate global resources, they will play an even more significant role in the restructuring of global value chains.

Image caption: Cheng Haotian, Founder and CEO of Gaussian Robotics

During the discussion session, Liu Ji, Partner at BlueRun Ventures, moderated a roundtable forum, where Yao Xin, Co-founder and CEO of PPIO; Zhang Nanxiong, Co-founder and Director of WenZhi TCM; and Li Tianlai, Managing Director of C Capital, explored from different angles the global competitiveness of Chinese technology assets, shifts in global capital allocation patterns, and Hong Kong's strategic role in this landscape.

Image caption: Roundtable forum

Having founded PPTV in the internet and mobile internet era and PPIO in the intelligent technology era, Yao Xin, as a serial entrepreneur, has witnessed the development and leap of Chinese technology on the global stage. He proposed that China has gradually transformed from a "follower" to a "leader" in key technology domains, with many Chinese enterprises becoming pivotal players in global markets through technological innovation and globalization strategies, attracting long-term capital from around the world. Patient capital provides the necessary financial runway for high-risk, high-return R&D in frontier technologies.

Zhang Nanxiong stated that WenZhi TCM combines artificial intelligence with traditional Chinese medicine, addressing real-world problems while achieving solid profitability, foreshadowing that the implementation of AI across thousands of industries will unleash even greater value. As an international financial center, Hong Kong has become a core hub for cross-border capital flows and the most important gateway for international investors to access Chinese technology assets. Through Hong Kong, global investors can access world-leading frontier innovations, high-growth sectors responsive to global demand, opportunities for valuation re-rating and asset diversification, and the integration of global value chains driven by Chinese technology. At the same time, Hong Kong provides an ideal platform for Chinese enterprises to expand globally.

Li Tianlai pointed out that technological breakthroughs, policy support, and the reconfiguration of global capital are driving Chinese technology assets to demonstrate remarkable investment value, transforming them into a "core growth engine" within global portfolios. Meanwhile, global assets are looking to the AI revolution to drive long-term growth in the future. Although risks remain, the integration of China's domestic circulation with the global ecosystem endows Chinese technology assets with long-term resilience. He advised that global investors should adopt a longer-term perspective and prioritize Chinese tech enterprises listed in Hong Kong, sharing in the fruits of China's technological innovation.

Image caption: Liu Ji, Partner at BlueRun Ventures, moderates the roundtable forum.

Liu Ji concluded that as a model of patient capital, HKIC invests not only at the growth stage but also works hand-in-hand with startups and early-stage funds to build a technology ecosystem, strongly supporting Hong Kong's ambition to become a global technology hub. The strategic partnership between BlueRun Ventures and HKIC not only provides financial support for China's top technology talent but also contributes to building a more complete technology ecosystem. With the fund's activation, there is reason to expect more high-quality investment projects to emerge in the future, further driving Chinese technological innovation to exert greater influence on the global stage.

Congratulations on the successful hosting of the inaugural "Hong Kong Startup Investment and Development Summit"

HKIC Partners with Galaxy Universal to Expand Hong Kong Ecosystem, AI-Powered Humanoid Robot Interacts On-Site, Embodied Intelligence Gathers Innovation Talent | BlueRun Family Headlines

How Can Tech Enterprises Seize New Opportunities in Hong Kong? | BlueRun Family Visits Hong Kong Economic and Trade Office in Beijing